Marijuana Users Report High Rates Of Dependence In Global Drug Survey

Before reading this article, please understand that I am a strong supporter of legally obtained medical marijuana for the purpose of healing sicknesses and diseases and for the purpose of minimizing unrelenting chronic pain.  I am NOT a supporter of medical marijuana for recreational use, as this represents the purposeful desire of it’s users to ‘run away’ as is the case with other drugs.  For kids, it’s been proven as a gateway drug for addiction to both legal and illegal drugs as well as alcohol.

Here’s the article…

A large percentage of marijuana users around the world report signs of dependence, even as cannabis appears to be one of the safest and most commonly used drugs overall, according to the results of a survey released on Wednesday.

The findings are contained in the 2018 Global Drug Survey, a detailed questionnaire that compiled responses from more than 130,00 people in over 40 countries in the past year. One section of the survey used the “Severity of Dependence Scale,” or SDS, a popular tool that asks respondents five questions regarding impaired control over drug use and anxieties related to consumption and quitting.

Around 50,000 of the survey respondents reported having used marijuana in the last 12 months. Only alcohol and tobacco use were more common.

Of all cannabis users, 20.2 percent showed substantial signs of dependence, measured by affirmative answers to at least four of the five SDS questions. Crystal methamphetamine was the drug most closely associated with dependence, with nearly 25 percent of users scoring four or higher on the SDS.

Just over 20 percent of cannabis users around the world showed significant signs of dependence, according to the 2018 Gl

GLOBAL DRUG SURVEY
Just over 20 percent of cannabis users around the world showed significant signs of dependence, according to the 2018 Global Drug Survey.

A positive SDS score is not the same as a clinical diagnosis of dependence, Adam Winstock, a British addiction psychiatrist and founder of the Global Drug Survey, told HuffPost. But it does suggest that many marijuana users have considerable misgivings about their habits.

“You’ve got 20 percent of the people who are significantly worried about the impact of their use on their life,” said Winstock. “It’s a measure of subjective worry and concern, but those questions tap into things like how much you use, how often, your sense of control and your desire to stop.”

The responses to individual SDS questions offer a window into some of those feelings of dependence.

Cannabis was the substance most frequently associated with anxiety over the prospect of quitting, for example. Although nearly 74 percent of users said the idea of stopping “never or almost never” made them anxious, 19.7 percent said it “sometimes” did, with the rest reporting that it “often” or “always” did.

A total of 21.4 percent of marijuana users said it would be “quite difficult” for them to stop using, with 6.4 percent responding that it would be either “very difficult” or “impossible.” Around 72 percent said quitting would not be difficult.

Nearly 30 percent of cannabis users reported that their cannabis use was at least occasionally “out of control,” with 22.6 percent of respondents saying it was only “sometimes” an issue, 5.3 percent saying it was “often” an issue and 1.6 percent saying it was “always or nearly always” an issue.

Respondents to the 2018 Global Drug Survey were asked five questions on the Severity of Dependence Scale (SDS) to examin

GLOBAL DRUG SURVEY
Respondents to the 2018 Global Drug Survey were asked five questions on the Severity of Dependence Scale (SDS) to examine potential concerns regarding substance use.

The survey also sought to measure the overall safety of substances by asking respondents if they’d sought emergency medical treatment after using various drugs. Just 0.5 percent of all cannabis users reported seeking treatment after use, the second-lowest rate of any substance. Magic mushrooms appeared to be the safest recreational drug for the second year in a row, with just 0.2 percent of users saying they’d pursued medical intervention.

The cannabis dependence results were particularly surprising to Winstock, who said he would’ve expected to see around 10 to 15 percent of marijuana users report signs of dependence.

“You’re legalizing a drug that a fair number of people who use it have worries about themselves,” Winstock said. “The question is what do you do about that?”

The Global Drug Survey may hold some answers. Since 2014, the independent research company has partnered with medical experts and media groups to conduct an annual survey with the goal of making drug use safer through increased access to education and treatment resources.

Around 300,000 marijuana users have partaken in Global Drug Surveys over the years, said Winstock. Those respondents have consistently shown high levels of support for establishing government guidelines around safe marijuana use. Among cannabis users who have expressed a desire to use less frequently or quit entirely, many have said they’d like assistance in doing so. But very few end up seeking help.

You’re legalizing a drug that a fair number of people who use it have worries about themselves. The question is what do you do about that?Adam Winstock, founder of the Global Drug Survey

Taken together, the surveys suggest elected officials and the marijuana industry should be engaging in a more honest discussion about the risks associated with cannabis use so they can better address issues that may arise as laws are liberalized, said Winstock.

That advice may be particularly salient in the U.S., where a number of states are considering legalizing recreational marijuana in the face of growing public opposition to prohibition. Eight states, as well as Washington, D.C., have already legalized weed.

“Clearly arresting someone and giving them a criminal record for smoking a joint is a futile and pointless exercise and … nothing I’m suggesting is me saying cannabis is a bad drug and the government made a mistake,” said Winstock.

“What I’m saying is that at the point they regulated cannabis, they should have mandated a whole bunch of things that allowed it to be easier for people to reflect on their cannabis use and how it impacted on them and how to control their use,” he went on. “There should have been mandated health warnings and advice and an index of harm for different products.”

Among the 3,400 U.S. marijuana users surveyed this year, just under 25 percent expressed a desire to use less ― compared to 29.3 percent of users globally. Just over 25 percent reported getting high more than 300 days out of the past year, though that may not be reflective of broader marijuana trends, because the survey didn’t randomly sample users nationwide.

Sixteen percent of the American marijuana users who said they wanted to cut back also responded that they’d like help doing so. Nearly 50 percent of all U.S. users said they’d attempted to quit at some point, with 67 percent of those saying they’d tried in the previous year.

Winstock says it makes sense to increase access to harm reduction tools in order to reach those who say they want help with their dependence on cannabis. But broad support for this sort of comprehensive approach requires people on all sides to confront the fact that marijuana, like pretty much any drug, can lead to dependence with some frequency.

Stop for a moment and think about how you cannot become the tobacco industry or the alcohol industry.Adam Winstock, founder of the Global Drug Survey

Instead, the legalization debate has played out in a far more polarized fashion, with advocates often pushing back against decades of government anti-weed hysteria by claiming cannabis is a harmless drug, especially when compared to alcohol or tobacco.

In light of the cataclysmic failures of the nation’s war on drugs, there is plenty of reason to be tempted by that portrayal.

“It could just be that so many people are saying we’ve raised billions in taxes, saved thousands of hours of police time, saved loads of innocent young lives from having their careers ruined and being banged up in prison,” said Winstock. “Those are such huge wins that I could see people going, ‘That’s enough.’”

But just because the status quo has been so bad for so long and marijuana is less harmful than alcohol or tobacco ― legal drugs that kill more people each year than all illicit drugs combined ― doesn’t mean the push to legalize cannabis can’t learn from past mistakes.

For Winstock, it’s not too late for legal weed states and leaders in the marijuana industry to place more focus on public health.

“Stop for a moment and think about how you cannot become the tobacco industry or the alcohol industry,” said Winstock. “Be the best you can be, don’t just make the biggest profit. Be the most responsible industry you can, and that means be honest.”

Read the entire 2018 Global Drug Survey here.

The original article can be found by clicking here.


Faith based recovery that is compassionate, empathetic, transformational, non-12 step, without disease theories, individualized, and delivered to you online and by phone – with 24/7 support for life! Please CLICK HERE.

Trump Paves Way For United States Marijuana Legalization

President Trump has been under fire for the past week. He’s battled liberals over Stormy Daniels. He’s battled Libertarians and non-interventionists over the current situation in Syria, a decision which could ultimately begin a proxy war with Russia and Iran. And he’s battled liberals over (insert anything).

But he may have just, once again, pulled the proverbial rabbit from the hat. And the big pharmaceutical companies aren’t going to be thrilled.

Trump has paved the way for U.S. marijuana legalization, a move that sent many of the top marijuana stockss kyrocketing and a number of Democrats applauding. President Trump will essentially withdraw federal objections to state marijuana legalization ambitions.

If Trump is to proceed, which does seem likely, this would be a huge reform of federal marijuana laws, which is currently prohibited. It means states would no longer need to contend with the federal government when implementing marijuana legislation.

Democrats like Colorado Senator, Cory Gardner, was thrilled by the announcement.

“Since the campaign, President Trump has consistently supported states’ rights to decide for themselves how best to approach marijuana,” U.S. Sen. Cory Gardner (D-CO) said in a statement. “Late Wednesday, I received a commitment from the President that the Department of Justice’s rescission of the Cole memo will not impact Colorado’s legal marijuana industry. Furthermore, President Trump has assured me that he will support a federalism-based legislative solution to fix this states’ rights issue once and for all.”

We’d be hard-pressed not to attempt to draw a conclusion between Trump’s move being a rather timely shot at current Attorney General, Jeff Sessions, who has been rumored to potentially be fired soon. Clearly, Gardner’s statement confirms that Trump’s held this ambition from day one, but I would imagine the timing is somewhat strategic on a multitude of levels.

But more bitter than Sessions is likely executives at pharmaceutical companies who have boldly donated to fighting against marijuana legalization in the United States. A chart posted by the Washington Post back in 2016 shows exactly why pharmaceutical companies would be a bit uneasy with impending marijuana legislations all throughout the United States.

trump marijuana

Those statistics are nothing short of stunning. The fact is, fully legalized marijuana would allow millions of people suffering from chronic pain to at least try marijuana as an option (legally). They’d not need a pricey prescription nor have to purchase from black market sources

The above article, in original format, can be found here.


Need truly affordable help in recovery? Want a permanent solution for addiction? Don’t want to do ‘steps’ or be told that you have a (theorized) disease? Resent being called an ‘addict’ – even when you’re past your addiction? Want your recovery to remain private, be compassionate, and individualized just for you? Want a faith based solution? Would you like to recover from the privacy of your home or office? Don’t want recovery to interfere in your activities of daily living? A FREE, no obligation, 30 minute conversation by phone is waiting for you; however, for those who truly cannot afford our program and can demonstrate their need with verifiable documentation, the program is given FREE. Please CLICK HERE!
As a registered non profit corporation, we’re currently working hard to obtain grants, donations and funding so that we can provide you with a totally FREE program – if you are unable to afford our low cost.

 

First Of Its Kind Study Shows Undeniable Evidence Cannabis Can Cure Opioid Addiction

Scientists have shown that CBD actually blocks the opioid receptor in the brain, leaving no more doubt that cannabis should be a primary treatment for addiction.

As the opioid epidemic rages on, those professing to seek “solutions” are willfully ignoring one of the most promising treatments – medical cannabis. When the Comprehensive Addiction & Recovery Act (CARA) was being debated in 2016, amendments to study medical cannabis were stripped out.

This happened despite studies showing that medical cannabis eases neuropathic pain, and the government’s own National Institutes of Health stating, “Medical marijuana products may have a role in reducing the use of opioids needed to control pain.”

There were also studies showing that deaths from opioids plummet in states with legal cannabis, and that 80 percent of cannabis users give up prescription pills. A Feb. 2017 study confirmed that opioid dependence and overdoses dropped significantly in medical cannabis states.

In January 2017, the National Academies of Science published an exhaustive review of the scientific literature and found that one of the most promising areas in medical cannabis is for the treatment of chronic pain.

But all of this falls on deaf ears to those in the pockets of Big Pharma, which is largely to blame for getting America hooked on opioids, as described in a Harvard analysis.

Now, a new experimental study has shown exactly how cannabis works to treat opioid addiction – by actually blocking the opioid reward in the brain.

“This study sought to determine whether the cannabis constituent cannabidiol attenuates the development of morphine reward in the conditioned place preference paradigm. Separate groups of mice received either saline or morphine in combination with one of four doses of cannabidiol using three sets of drug/no-drug conditioning trials. After drug-place conditioning, morphine mice displayed robust place preference that was attenuated by 10 mg/kg cannabidiol. Further, when administered alone, this dose of cannabidiol was void of rewarding and aversive properties. The finding that cannabidiol blocks opioid reward suggests that this compound may be useful in addiction treatment settings.

The use of cannabidiol (CBD), one of two major active ingredients in cannabis, is even more promising for legalization effiorts because it does not produce the high that THC does. So prohibitionists who demonize cannabis’ intoxicating effect have no ammo when it comes to CBD. CBD can even be extracted from hemp, which is grown for its fiber used in thousands of manufacturing applications.

Because it can’t get anyone high, CBD extracts are even being permitted for medical use in staunchly prohibitionist states such as Oklahoma and Utah, to treat children with intractable epilepsy.

States have been reluctant to approve opioid addiction as a valid condition for prescribing medical cannabis. Big Pharma, having already secured their grip on federal government, has undoubtedly been working over state governments to prevent cannabis from threatening their profits. They had a measure of success in Arizona, which failed vote for legalization after pharma companies donated heavily to anti-pot propaganda campaigns.

The new study showing how CBD blocks the opioid reward will certainly prompt more research. This, coupled with statistical evidence from medical cannabis states, should finally prove fatal to the irrationality of blocking cannabis for opioid addiction treatment.

The source for the above article can be found by clicking here.


Need truly affordable help in recovery? Want a permanent solution for addiction? Don’t want to do ‘steps’ or be told that you have a (theorized) disease? Resent being called an ‘addict’ – even when you’re past your addiction? Want your recovery to remain private, be compassionate, and individualized just for you? Want a faith based solution? Would you like to recover from the privacy of your home or office? Don’t want recovery to interfere in your activities of daily living? A FREE, no obligation, 30 minute conversation by phone is waiting for you; however, for those who truly cannot afford our program and can demonstrate their need with verifiable documentation, the program is given FREE. Please CLICK HERE!
As a registered non profit corporation, we’re currently working hard to obtain grants, donations and funding so that we can provide you with a totally FREE program – if you are unable to afford our low cost.

 

Cannabidiol (CBD Oil) ~ Benefits for Pain, Mental Illness & Anxiety

The article below is, in my humble opinion, a well balanced article about medical marijuana and how the true benefits are in the CBD oil – not the THC.  The THC can cause mental health issues and paranoia; the higher the CBD – in balance with some THC – is what lowers those issues.  I would venture a guess that if you need the THC for medicinal reasons, it would be best to dramatically add pure CBD oil to reduce those mental health issues that THC tends to create.

The use of medical marijuana continues to be an emotionally and politically charged issue. Although cannabis oil preparations have been used in medicine for millennia, the concern over the dangers of abuse led to the banning of the medicinal use of marijuana in the 1930s.

Only recently, marijuana and chemically related compounds have come back to being considered of therapeutic value. A prominent compound found in marijuana or cannabis, CBD, or cannabidiol, has shown to treat numerous diseases. Researchers believe that in view of the very low toxicity and the generally benign side effects of CBD, neglecting or denying CBD benefits and its clinical potential is simply unacceptable.


What Is CBD?

CBD is one of over 60 compounds found in cannabis that belong to a class of ingredients called cannabinoids. Until recently, THC (tetrahydrocannabinol) was getting most of the attention because it’s the ingredient in cannabis that produces mind-altering effects in users, but CBD is also present in high concentrations — and the medical world is realizing that its list of medical benefits continues to grow.

CBD is the major nonpsychoactive component of Cannabis sativa. According to a 2013 study published in the British Journal of Clinical Pharmacology, CBD benefits including acting in some experimental models as an anti-inflammatory, anticonvulsant, antioxidant, antiemetic, anxiolytic and antipsychotic agent, and is therefore a potential medicine for the treatment of neuroinflammation, epilepsy, oxidative injury, vomiting and nausea, anxiety and schizophrenia. (1)

Research is beginning to show that CBD is different than other well-studied cannabinoids. All cannabinoids act as ligands, meaning they dock onto the binding site of a protein and have the ability to modulate a receptor’s behavior. CB1 receptors are widely distributed, but are particularly abundant in areas of the brain, including those concerned with movement, coordination, pain and sensory perception, emotion, memory, cognition, autonomic and endocrine functions. (2)

CB2 receptors are found mostly in the immune system, and they seem to reduce inflammation and certain kinds of pain. Although cannabinoids all have similar structures, they display a wide array of actions at each of the different receptors.

However, scientists are finding out that CBD has very little effect on CB1 and CB2 receptors, which probably explains why it doesn’t have mind-altering effects, unlike THC, which positively regulates the CB1 receptor. That’s why most marijuana grown for recreational purposes are typically very low in CBD and high in THC. (3)


8 Proven Benefits of CBD

1. Relieves Pain and Inflammation

Among common CBD benefits, natural pain relief tops the list for many. Evidence suggests that cannabinoids may prove useful in pain modulation by inhibiting neuronal transmission in pain pathways. A 2012 study published in the Journal of Experimental Medicine found that CBD significantly suppressed chronic inflammatory and neuropathic pain in rodents without causing analgesic tolerance. Researchers suggest that CBD and other nonpsychoactive components of marijuana may represent a novel class of therapeutic agents for the treatment of chronic pain. (4)

According to a 2007 meta-analysis conducted in Canada, the combination of CBD and THC buccal spray was found to be effective in treating neuropathic pain in multiple sclerosis, which can be debilitating for 50 to 70 percent of MS patients. (5)

2. Has Antipsychotic Effects

Research shows that CBD benefits include producing antipsychotic effects. It appears to have a pharmacological profile similar to that of atypical antipsychotic drugs as seen using behavioral and neurochemical techniques in animal studies. Additionally, studies show that CBD prevents human experimental psychosis and is effective in open case reports and clinical trials in patients with schizophrenia, with a remarkable safety profile. (6)

3. Reduces Anxiety

Studies using animal models of anxiety and involving healthy volunteers clearly suggest an anxiolytic-like effect of CBD. Cannabidiol has shown to reduce anxiety in patients with social anxiety disorder and researchers suggest that it may also be effective for panic disorder, obsessive compulsive disorder, social anxiety disorder and post-traumatic stress disorder. (7)

A 2011 study aimed to compare the effects of a simulation public speaking test on healthy control patients and treatment-native patients with social anxiety disorder. A total of 24 never-treated patients with social anxiety disorder were given either CBD or placebo 1.5 hours before the test. Researchers found that pretreatment with CBD significantly reduced anxiety, cognitive impairment and discomfort in their speech performance, and significantly decreased alertness in anticipation of their speech. The placebo group presented higher anxiety, cognitive impairment and discomfort. (8)

4. Helps to Fight Cancer

Several scientific reports demonstrate that CBD benefits include possessing antiproliferative, pro-apoptotic effects that inhibit cancer cell migration, adhesion and invasion. (9) A 2006 study published in the Journal of Pharmacology and Experimental Therapeutics found for the first time that CBD potently and selectively inhibited the growth of different breast tumor cell lines and exhibited significantly less potency in non-cancer cells. (10)

In 2011, researchers added light on the cellular mechanism through which CBD induces cell death in breast cancer cells. They showed that CBD induced a concentration-dependent cell death of both oestrogen receptor-positive and oestrogen receptor-negative breast cancer cells. They also found that the effective concentrations of CBD in tumor cells have little effect on non-tumorigenic, mammary cells. (11)

CBD behaves as a non-toxic compound and studies show that doses of 700 milligrams per day for 6 weeks did not show any overt toxicity in humans, suggesting that it can be used for prolonged treatment. Not only does the research show that CBD benefits including being effective in fighting breast cancer cells, data also suggests that it can be used to inhibit the invasion of lung and colon cancer, plus it possesses anti-tumor properties in gliomas and has been used to treat leukemia. (12)

CBD guide - Dr. Axe

5. Relieves Nausea

Cannabis has been used for centuries for the suppression of nausea and vomiting. Research has revealed that among more than 80 cannabinoid compounds found in marijuana, both the intoxicant THC and the non-intoxicant CBD helps to get rid of nausea and vomiting in animal studies. A 2012 study published in the British Journal of Pharmacology found that CBD benefits including possessing anti-nausea and antiemetic effects when it was administered to rats. (13) Researchers found that CBD acts in a diphasic manner, meaning that in low doses it suppresses toxin-induced vomiting, but in high doses it increases nausea or has no effect.

6. May Treat Seizures and Other Neurological Disorders

A 2014 survey conducted by researchers at Stanford University was presented to parents belonging to a Facebook group dedicated to sharing information about the use of cannabidiol-enriched cannabis to treat their child’s seizures. Nineteen responses met the inclusion criteria for the study: a diagnosis of epilepsy and current use of CBD-enriched cannabis. The average number of anti-epileptic drugs tried before using CBD cannabis was 12. Sixteen (84 percent) of the 19 parents reported a reduction in their child’s seizure frequency while taking CBD cannabis. Of these, two (11 percent) reported complete seizure freedom, eight (42 percent) reported a greater than 80 percent reduction in seizure frequency, and six (32 percent) reported a 25–60 percent seizure reduction. Other beneficial effects included increased alertness, better mood and improved sleep; while side effects included drowsiness and fatigue. (14)

Later in 2014, researchers reported on preliminary results of a study involving children with treatment-resistant epilepsies in an expanded access “compassionate use program.” Patients received a purified 98 percent oil-based CBD extract called Epidiolex, which is made by GW Pharmaceuticals. After 3 months of treatment, 39 percent of the 23 patients had more than a 50 percent reduction in seizures, with a 32 percent median reduction. These preliminary results support the animal studies and survey reports that CBD may be a promising treatment for treatment-resistant epilepsy and it is generally well-tolerated in doses up to 25 milligrams per kilogram of body weight. (15)

7. Lowers Incidence of Diabetes

A 2006 study found that CBD treatment significantly reduced the incidence of diabetes in non-obese diabetic mice from an incidence of 86 percent in non-treated mice to an incidence of 30 percent in CBD-treated mice. CBD benefits also showed a significant reduction of plasma levels of pro-inflammatory cytokines. A histological examination of the pancreatic islets of the CBD-treated mice revealed significantly reduced insulitis. (16)

In 2013, the American Journal of Medicine published a study that highlighted the impact of marijuana use on glucose, insulin and insulin resistance among U.S. adults. The study included 4,657 adult men and women from the National Health and Nutritional Examination Survey from 2005 to 2010. Of the participants, 579 were current marijuana users and 1,975 were past users. The researchers found that current marijuana use was associated with 16 percent lower fasting insulin levels. They also found significant associations between marijuana use and smaller waist circumferences, a factor connected to the onset of diabetes symptoms. (17)

8. Promotes Cardiovascular Health

A 2013 study published in the British Journal of Clinical Pharmacology reports that CBD protects against the vascular damage caused by a high glucose environment, inflammation or the induction of type 2 diabetes in animal models; plus, CBD proved to reduce the vascular hyperpermeability (which causes leaky gut) associated with such environments. (18)


CBD vs. THC

CBD and THC are the two main compounds in the marijuana plant and they are the only two cannabinoids that have been well characterized to date. Many strains of marijuana are known for having abundant levels of THC and high-CBD strains are less common; however, with the medical community paying more attention to the therapeutic effects of CBD, that is beginning to change.

Both compounds have important health benefits: THC has antispasmodic, analgesic, anti-tremor, anti-inflammatory, appetite stimulating and anti-emetic properties, and CBD has anti-inflammatory, anticonvulsant, antipsychotic, antioxidant, neuroprotective and immunomodulatory effects.

The clinical use of THC is often limited by its unwanted psychoactive side effects, and for this reason interest in non-psychoactive phytocannabinoids, such as CBD, has substantially increased in recent years. In fact, CBD is being used to reduce the intoxicating effects of THC, such as paranoia and memory impairment. (19)

CBD also appears to counteract the sleep-inducing effects of THC. This is what makes CBD so appealing to the medical community, as the cause of psychoactive side effects has been a major barrier in the acceptance of medical marijuana. (20) While THC is known to cause anxiety and paranoia in some people, CBD works to counteract those side effects. For this reason, CBD benefits extend to being used in clinical trials on young children with epilepsy.

Another major difference between THC and CBD is that marijuana with high levels of THC is commonly used for its sleep-inducing effects, while CBD appears to promote wakefulness instead. (21)


How to Legally Acquire CBD

At the federal level, CBD is classified as a Schedule 1 drug in the United States because it is one of the many cannabinoids present in marijuana. To be labeled a schedule 1 drug means that it has a high potential for abuse and the potential to create severe psychological or physical dependence; therefore these drugs are not allowed to be used for medical use.

Medical research can and is being done with schedule 1 substances, including CBD and other active ingredients in marijuana, but there are strict regulations and administrative hurdles associated with this status. According to the Federation of American Societies for Experimental Biology, the DEA is currently conducting a scientific review of CBD to elucidate its pharmacology and abuse liability and to identify gaps in the published literature. (22)

In 1996, California voters passed Proposition 215, allowing for the use of medical marijuana. Since then, 27 more states, plus the District of Columbia, Guam and Puerto Rico have enacted similar laws that allow for comprehensive public medical marijuana and cannabis programs.

More recently, 17 states have approved the use of low THC, high CBD products for medical reasons in limited situations. Each state has specific requirements and conditions that need to be followed in order to use CBD legally, such as patient registry requirements and definitions of products that are allowed. (23) The 17 states that allow limited access to marijuana products low in THC and high in CBD include:

  • Alabama
  • Florida
  • Georgia
  • Iowa
  • Kentucky
  • Louisiana
  • Mississipi
  • Missouri
  • North Carolina
  • Oklahoma
  • South Carolina
  • Tennessee
  • Texas
  • Utah
  • Virginia
  • Wisconsin
  • Wyoming
  • Idaho (vetoed by governor in 2015)

Precautions

Although the research on the medicinal use of cannabis is strong, several studies indicate that the recreational use of cannabis can have persistent adverse effects on mental health. According to a 2013 report published in Frontiers in Psychiatry, depending on how often someone uses, the age of onset, the potency of the cannabis that is used and someone’s individual sensitivity, the recreational use of cannabis may cause permanent psychological disorders. Most recreational users will never be faced with such persistent mental illness, but in some individuals cannabis use leads to undesirable effects, including cognitive impairment, anxiety, paranoia and increased risks of developing chronic psychosis or drug addiction. (24)

Some studies show that CBD can counteract these adverse effects, but more research is needed, as most of this research is done on animals or is based on anecdotal reports. Little research has focused on the safety and side effects of CBD in humans; however, clinical trials indicate that only a few, generally mild side effects have been observed after CBD administration and tolerance for CBD does not seem to occur.


Final Thoughts

  • CBD is one of over 60 compounds found in cannabis that belong to a class of ingredients called cannabinoids; it is the major nonpsychoactive component of Cannabis sativa.

  • Research shows that CBD benefits include acting as an anti-inflammatory, anticonvulsant, antioxidant, antiemetic, anxiolytic and antipsychotic agent, and is therefore a potential medicine for the treatment of neuroinflammation, epilepsy, oxidative injury, vomiting and nausea, anxiety and schizophrenia.

  • Many strains of marijuana are known for having abundant levels of THC and high-CBD strains are less common; however, with the medical community paying more attention to the therapeutic effects of CBD, that is beginning to change. CBD is being used to reduce the intoxicating effects of THC, such as paranoia and memory impairment.

  • 17 states have approved the use of low THC, high CBD products for medical reasons in limited situations. Each state has specific requirements and conditions that need to be followed in order to use CBD legally, such as patient registry requirements and definitions of products that are allowed.

For this original article, please CLICK HERE.


CBD pure cbd affiliate

FDA DISCLOSURE

Representations regarding the efficacy and safety of CBDPure have not been evaluated by the Food and Drug Administration. The FDA only evaluates foods and drugs, not supplements like these products. These products are not intended to diagnose, prevent, treat, or cure any disease. Click here and here to find evidence of a test, analysis, research, or study describing the benefits, performance or efficacy of CBD Oil based on the expertise of relevant professionals.

These statements have not been evaluated by the FDA and are not intended to diagnose, treat, or cure any disease. Always check with your physician before starting a new dietary supplement program.

The Cannabidiol (CBD) in CBDPure is a natural constituent of industrial hemp plant and grown in the United States of America. CBDPure does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US CSA).

Cannabis Over Chemo: Woman Says the Oil Cured Her Aggressive Breast Cancer in 5 Months

When Dee Mani, now 44, was diagnosed with breast cancer last March, her doctors suggested chemotherapy. She originally agreed to undergo one year of the treatment for her triple negative breast cancer – the deadliest type – but later had second thoughts. After seeing her sister suffer and die after undergoing chemotherapy for cancer, the mother of two set out to find an alternative.

She decided to take cannabis oil after researching natural cancer remedies online. She said she took one drop inside a capsule every night before going to bed because she didn’t care for the taste or texture of it on its own. Four months after her original diagnosis, her cancer had reduced significantly, and her doctors gave her the all-clear in August, just five months after starting cannabis oil.

She continues to take it to this day and says she plans to do so for the rest of her life as it has also helped her with problems like insomnia, a dust allergy, and back pain caused by slipped discs. She has also changed her diet and taken up meditation.

Lots of cannabis oil cancer treatment success stories

Stories like Mani’s are becoming less and less unusual as more people give cannabis oil a try. For example, a 33-year-old U.K. father, David Hibbitt cured what doctors deemed a “terminal” case of colon cancer with cannabis oil after radiation, chemotherapy and surgery all failed him. He had initially rejected the idea, but after being told he had just 18 months left to live, he was willing to try anything. Hibbitt used a high-potency variety known as Phoenix Tears (aka: Rick Simpson Oil or RSO) and is now cancer-free. He also said that his “pain just seemed to disappear.”

In another of the many stories that have emerged of cancer being successfully treated with cannabis oil, a three-year-old boy in Utah who was given just days to live by doctors because of leukemia is thriving thanks to the oil. After two months of chemo, Landon Riddle was refusing to eat and vomiting dozens of times a day. After researching cannabis oil treatment online, his family traveled to Colorado to gain access to it. After just a few days, his vomiting eased, his appetite returned, and he was showing signs of improvement. Months after the ordeal, he, too, was free of cancer.

Then there is the case of Darren Miller, who found out he had lung and pericardial heart sac cancer on the day he turned 50. Given just a year to live with chemotherapy, he and his wife decided to move to California, where he would be able to use cannabis oil. Seven months later, he was cancer-free. He believes it was the combination of chemotherapy and cannabis oil that cured his cancer.

Unfortunately, until there is more widespread acceptance of this type of treatment, it’s possible that some people who could benefit from it simply won’t be aware or willing to give it a try. Of course, there’s also the fact that should cannabis oil treatment go mainstream, Big Pharma would lose out on the billions of profits it makes from the cancer industry. While some people have found success using cannabis oil in conjunction with chemotherapy, others have found it to be effective on its own, illustrating that the most mainstream method isn’t necessarily the only or best way to solve a problem.

Click to original article HERE.


Individualized and compassionate faith based addiction recovery delivered over 3 months online and by phone, with 24/7 support.  Completely affordable to just about anyone.  Please CLICK HERE to find out more.  We offer a FREE, no obligation, 30 minute consultation to fully discuss our program and answer your questions.

Medical Cannabis Use Found to Dramatically Decrease Reliance on Addictive Prescription Medications

I have to preface the following NaturalNews.com article with a few points.  As my readers know, I am dead set against prescription drugs and other drug use and am very active in ministry and in teaching, taking people through recovery and bringing awareness to addiction and prevention.  The note I need to make is that I am not against medical marijuana; however, I am very against recreational use of medical marijuana.  Smoking and vaping it, in my opinion and according to my research, is highly toxic and has disease producing potential.  I advocate medical marijuana in capsule form, juiced raw and in edibles.  That all said, please read the article below.

Taking medical cannabis may significantly reduce the need for prescription medications, a recent study revealed.

As part of research, a team of health experts at the University of New Mexico examined patients who voluntarily enrolled in the New Mexico state medical cannabis program. The patients were also on scheduled prescription medications.

Prescription drug use was reported to the New Mexico Prescription Monitoring Program. Opiates and benzodiazepines were among the most common drugs that the patients used.

According to the research team, patients enrolled in the medical cannabis program have significantly lower monthly average number of prescriptions than those who did not enroll in the program. Enrolled patients also reduced the types of prescription drugs they took as well as the number of prescribers and related pharmacy visits, the scientists noted.

In addition, the health experts found that up to 71 percent of enrolled patients either ceased or reduced their use of scheduled prescription drugs within six months following enrollment.

The study was slated for publication in the Journal of the American Medical Directors Association.

Previous studies support link between cannabis use, lower Rx drug use

The recent results coincide with findings from two studies published last year.

In one study, a team of researchers at the University of Michigan School of Public Health and Medical School examined 185 patients from a medical marijuana dispensary in Ann Arbor between November 2013 to February 2015.

The research team found that patients who took medical marijuana to treat chronic pain exhibited a 64 percent reduction in their use of more traditional, opioid-based medications. The experts also noted fewer side effects and a 45 percent increase in quality of life in patients who took medicinal cannabis.

Study lead author Kevin Boehnke stressed that the country is in the midst of an opioid epidemic, and said that the findings may hopefully lead to discussions about cannabis being a potential alternative to opioid treatment.

“We are learning that the higher the dose of opioids people are taking, the higher the risk of death from overdose. This magnitude of reduction in our study is significant enough to affect an individual’s risk of accidental death from overdose. We hypothesized that cannabis might be particularly effective for the type of pain seen in conditions such as fibromyalgia, since there are many studies suggesting that synthetic cannabinoids work in these condition. We did not see this because the patients in this study rated cannabis to be equally effective for those with different pain severity,” senior author Dr. Daniel Clauw said in a university release.

Another study showed U.S. states that legalized medicinal cannabis use saw a significant decline in prescription drug use among  the elderly and disabled population.

As part of the study, researchers at the University of Georgia assessed prescription data for nine conditions — such as anxiety, depression, seizures and glaucoma — in which medicinal marijuana may be of great use. (Related: Cannabis Compounds Found To Be SUPERIOR To Migraine Drugs.)

The scientists found that fewer prescriptions were written for each condition except for glaucoma in states where medicinal cannabis was allowed. Researchers said medicinal cannabis lowers eye pressure in glaucoma patients, but the effects lasted for only an hour.

Study lead author Ashley Bradford said the results suggest that people are really using medicinal marijuana for health purposes and not just for recreation.

“It turns out that glaucoma is one of the most Googled searches linked to marijuana, right after pain. No doctor is going to let [a glaucoma] patient walk out without being treated. When states turned on medical marijuana laws, we did see a rather substantial turn away from FDA-approved medicine. The results show that marijuana might be beneficial with diverting people away from opioids,” study co-author David Bradford told CBC Newsonline.

Sources include:

NaturalNews.com

NewsWire.com

NS.UMich.edu

CBC.ca


Compassionate faith based online recovery is available HERE.

Hemp Eats Radiation, Cleans Toxic Metals From Soil

Big Pharma & Big Med would have you think that Hemp products are bad.  Quite the opposite.  There is no other plant that grows from our earth that is more versatile than Hemp. The healing properties seem to be endless. The only reason the medical community speaks against it is because they can’t get money from it!  Do your research!

By Brandon Turbeville

It appears the uses of hemp are endless. In addition to myriad industrial products such as paper, construction material, clothing, food and fuel, hemp is also known to draw out toxic substances from the soil. In other words, not only does hemp provide humans with innumerable products, it also helps to clean the environment of the mistakes we have made in the past. It has already been discovered that hemp may be extremely useful in the removal of cadmium from the soil and other toxic metals, as well as radiation.

In fact, hemp has been seen as so successful in removing radiation from the soil that it is even being considered for use in Fukushima for the purposes of drawing out radiation. the process by which hemp cleans polluted soil is called phytoremediation – a term given to the process of using green plants to clean up the environment or “remediate” soil or water that has been contaminated with heavy metals and excess minerals. Two plants that are members of the mustard family as well as sunflowers have been known to do the same for many years. And hemp is now finding itself in the same category.

As MintPress News wrote on October 6, 2015,

A group of representatives of Consolidated Growers and Processors, PHYTOTECH, and Ukraine’s Institute of Bast Crops experimented in the late 1990s with using industrial hemp, a form of the plant that’s high in fiber but low in psychoactive or medical benefits, near the site of the Chernobyl nuclear disaster, where a great deal of agricultural land is still unusable because of the presence of radiation and heavy metals still lingering from the 1986 meltdown.
“Hemp is proving to be one of the best phyto-remediative plants we have been able to find,” said Slavik Dushenkov, a research scientist with PHYTOTECH.
In 2009, scientists from Belarus also experimented with hemp in areas polluted by Chernobyl. The disaster contaminated nearly 20 miles around the site.
The Belarusian scientists noted that one added benefit of industrial hemp over other phytoremediation plants is that it can also be used to produce biofuel, potentially adding a second use for the crop after it removes toxins from the soil.
“As with the Chernobyl incident, scientists are finding radioactive emissions and toxic metals–including iodine, cesium-137, strontium-90, and plutonium–concentrated in the soil, plants, and animals of Japan, but also now throughout the United States and all along the West Coast – from Canada to Mexico,” Sarich wrote for Nation of Change.

As cannabis journalist and researcher Seshata notes in her article “Hemp and the Decontamination of Radioactive Soil” – a number of studies that demonstrate hemp’s durability in the face of pollutants as well as its ability to remove metals from the soil.

She writes:

Hemp’s resilience to contaminants in soil is well-documented. Even as early as 1975, a studypublished in the Agronomy Journal described how soil characteristics influenced elemental uptake and could even affect final cannabinoid profile in psychoactive strains. To illustrate this, fifteen sites with varying soil profiles were planted with the same strain of Afghan cannabis, and their harvests tested for metal content. Researchers concluded that differences could be used to determine geographic origin of cannabis through foliar analysis.

In 1995, the Polish Institute of Natural Fibres released a study demonstrating that tested varieties were able to withstand high levels of heavy metals in soil without impacting plant growth, yield or fibre quality. However, little research has been done into the safety of using fibres in clothing or other forms of industry, and this issue must be investigated fully in order to establish the possible uses for hemp grown in such conditions.

As a proven, valuable tool in the fight to repair human-inflicted damage to our soils and ecosystems, hemp could potentially benefit hundreds of thousands of sites across the globe—it is estimated that in the USA alone there are 30,000 sites requiring remediation. As is so often the case, US restrictions on hemp cultivation preclude any large-scale operations from being implemented, and the contaminated sites are largely left unremediated, through lack of both funding and interest on the part of the government.

While some researchers such as the Belarusian researcher above suggest that the hemp plants that have been used for phytoremediation purposes could then be used as a biofuel – the truth is, we simply don’t know if this is possible because the toxins may be once again released into the environment. Yet knowing that hemp can be used to extract the substances to begin with is itself an amazing discovery. Indeed, it seems we can chalk one more productive use for a plant that has been in the cross hairs of the law enforcement community, federal, state and local governments, corporations and other relevant monopoly interests. It is time the American people fully recognize benefits of hemp as a longterm solution to many issues and immediately demand that a senseless war on a plant be ended.